title: Reply.
authors.affiliation: Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Brad H
authors.initials: BH
authors.lastname: Rovin
authors.affiliation: Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Dan
authors.initials: D
authors.lastname: Birmingham
authors.affiliation: Mayo Clinic and Foundation, Rochester, MN and, Scottsdale, AZ.
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Cartin-Ceba
authors.affiliation: Mayo Clinic and Foundation, Rochester, MN and, Scottsdale, AZ.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Specks
authors.affiliation: Massachusetts General Hospital, Boston, MA.
authors.forename: John H
authors.initials: JH
authors.lastname: Stone
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic; D003520:Cyclophosphamide; D003577:Cytochrome P-450 Enzyme System; D010597:Pharmacogenetics; D017452:Receptors, IgG; D000069283:Rituximab
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D017452:Receptors, IgG; D000069283:Rituximab; D003520:Cyclophosphamide; D003577:Cytochrome P-450 Enzyme System